Sign In
test

Christabel Syham

Tri Locum Partners Lp

Assets Managed
$712.549M
Holdings
17
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
-7.47%(2Q avg: 34.78%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Tri Locum Partners Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 17 positions.

Assets under management

The assets under management (AUM) of Tri Locum Partners Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 712.549M in assets, with a quarterly growth rate of -7.47% and a 2-quarter average growth rate of 34.78%. The portfolio is managed by Christabel Syham, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
JNJ
Johnson & Johnson
Recent Activity
Decreased -31.27%
14.22%
$101.321M
414,503 shares@ $244.44 avg price
ISRG
Intuitive Surgical Inc
Recent Activity
New Position
9.92%
$70.647M
153,250 shares@ $461.0 avg price
TMO
Thermo Fisher Scientific Inc
Recent Activity
New Position
9.14%
$65.085M
132,413 shares@ $491.54 avg price
ASND
Ascendis Pharma A S - Adr
Recent Activity
Decreased -3.65%
8.2%
$58.402M
255,332 shares@ $228.73 avg price
VRTX
Vertex Pharmaceuticals Inc
Recent Activity
New Position
8.11%
$57.744M
129,314 shares@ $446.55 avg price
LLY
Eli Lilly & Co
Recent Activity
Decreased -2.35%
7.98%
$56.837M
61,795 shares@ $919.77 avg price
MDGL
Madrigal Pharmaceuticals Inc
Recent Activity
Increased 20.08%
7.59%
$54.068M
103,288 shares@ $523.47 avg price
DXCM
Dexcom Inc
Recent Activity
Increased 65.6%
6.16%
$43.844M
698,158 shares@ $62.8 avg price
UTHR
United Therapeutics Corp
Recent Activity
Decreased -41.8%
5.86%
$41.728M
70,370 shares@ $592.99 avg price
NUVL
Nuvalent Inc-a
Recent Activity
Increased 0.37%
4.44%
$31.606M
308,506 shares@ $102.46 avg price

1-10 of 17